Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-02

FDA Approved: EPLERENONE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' Original Application for a generic version of eplerenone (Inspra).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

ORIG AP for EPLERENONE (EPLERENONE)